Open Orphan

Open Orphan is a rapidly growing niche CRO pharmaceutical services company and a world leader in providing virology and vaccine challenge study services as well as virology laboratory services. hVIVO is the global leader in testing vaccines and antiviral drugs using human challenge study models and is developing the world's first coronavirus challenge study model. The company currently has a leading portfolio of 8 virus challenge study models, a portfolio unmatched by any other company in the world.